The global clinical trial packaging market size was valued at US$ 1.8 billion in 2021 and is expected to reach around US$ 3.7 billion by 2030, growing at a CAGR of 7.5% during the forecast period 2022 to 2030. The market is estimated to be driven by rising clinical trial activities coupled with rapid adoption of contract manufacturing in the pharma sector.
The clinical trial packaging solutions are used in various end-use industries for packaging, storing, protecting, and transporting clinical trial products. Clinical trial packaging solutions consist of syringes, vials & ampoules, blisters, tubes, bottles, etc. are predominantly used in research laboratories, clinical research organizations, and drug manufacturing facilities. The VRR team segmented the analysis of clinical trial packaging market based on packaging type, material, and end use. As per VRR analysis, research laboratories in the global clinical trial packaging market is expected to account for a lion’s share of the market, and expected to lead the overall clinical trial packaging market during the forecast period.
Innovative Concepts, Discovery of New Drugs to Fuel Market Growth
Research and development activities within the pharmaceutical sector have shifted gears in recent years, due to the increasing demand for new drugs and therapies– a factor that is expected to bolster the global clinical trial packaging market. The demand for glass bottles is on the rise owing to mounting concerns pertaining to the use of plastic. The consistent surge in the number of chronic diseases cases, including cancer, HIV, and epilepsy is expected to have a strong impact on the development of the global clinical trial packaging market during the assessment period. The rise in the number of research & development, along with the increasing support from governments for the development of new drugs, is anticipated to accelerate the growth of the global clinical trial packaging market during the assessment period.
Some of the factors that could hinder the growth of the clinical trial packaging market include lack of modern infrastructure in underdeveloped and developing regions and scarcity of trained personnel. Market players involved in the current clinical trial packaging market are increasingly focusing on developing their packaging solutions that can withstand filling, handling, transportation, etc. The advent of innovative pharmaceutical packaging concepts, including blow fill seal vials, two-in-one prefilled vial deigns, prefilled syringes, snap off ampoules, and child-resistant packs is projected to provide an impetus to growth of the global clinical trial packaging market during the assessment period.
Companies to Develop New Packaging Solutions to Hinder COVID-19 Spread
The advent of the COVID-19 pandemic is expected to have a strong influence on the clinical trial packaging market in 2020 and beyond. In the current scenario, market players are focusing on the development of new materials to meet packaging requirements during the COVID-19 crisis. The increasing demand for safe, sustainable, and hygienic packaging alternatives for healthcare products and eCommerce transportation is expected to augment the growth of the global clinical trial packaging market during the forecast period. The decline in the consumer demand for plastic packaging is anticipated to drive innovations across the clinical trial packaging market.
Due to the outbreak of the COVID-19 pandemic, the demand for medical device kits and certain medicines has witnessed exponential growth. This factor is expected to fuel the expansion of the global clinical trial packaging market. Furthermore, the contract packaging trend has gained considerable momentum during the COVID-19 crisis. Thus, the demand for pressure sensitive labels, folding cartons, and convenient vial filling has increased. Market players are also estimated to expand their manufacturing capacities during the ongoing pandemic to cater to the surge in the demand.
Current Trend of Contract Manufacturing in Pharmaceuticals Industry Drives Market
Manufacturers Target High Potential Asian Countries
Frequent Need of Booklet Labels in Clinical Trials Augment Sales
Key Findings
COVID-19 Impact: Rise in Clinical Trials Supplements Sales
Key Players
Some of the key players operating in the global clinical trial packaging market are Bilcare Limited, Westrock Company, Fisher Clinical Services, Almac Group Limited, PAREXEL International Corporation, The Coghlan Group, Piramal Enterprises Ltd, WuXi AppTec, PCI Pharma Services, and Pharmaterials Ltd, among others.
Market Segmentation
By Packaging Type
By Material
By End Use
Clinical Trial Packaging Market by Region
Scope of the Report
A new study on the global clinical trial packaging market, providing forecast for the period of 2021-2028. In the study, growth opportunity for the clinical trial packaging market is witnessed. The report provides valuable insights, which enable readers to make winning business decisions for future growth of their businesses. The report highlights significant factors that are constantly determining the growth of the clinical trial packaging market, untapped opportunities for manufacturers, trends & developments, and other insights across various key segments. Macroeconomic factors that are directly or indirectly affecting market growth are also incorporated in the report.
Key Questions
Key indicators associated with the clinical trial packaging market have been calculated thoroughly in the report. The study enumerates vital market dynamics such as key drivers, challenges, and trends, along with opportunities in the global clinical trial packaging market. A comprehensive study on the value chain, which includes component suppliers, manufacturers, distributors, and end users, has been incorporated in the global market report. Other key aspects laid down in the market include pricing strategy of leading market players and comparative analysis of clinical trial packaging. Furthermore, forecast factors and forecast scenarios of the clinical trial packaging market have been covered in the report to understand future prospects of the market.
A comprehensive evaluation and forecast on the clinical trial packaging market are provided on the packaging type, material, end use, and region.
Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The clinical trial packaging market is analyzed at both regional and country levels.
The report delivers an exhaustive assessment on the structure of the clinical trial packaging market, in tandem with a dashboard view of all leading company profiles in the report. Every company’s share analysis on market players have also been presented in the report, apart from the footprint matrix of profiled market players. The report depicts the presence of clinical trial packaging manufacturers by leveraging an intensity map. It also highlights key end uses for clinical trial packaging.
Research Methodology
A realistic methodology, along with a holistic approach makes the base for sharp insights, which are provided in the clinical trial packaging market for the study evaluation period. The report comprises of detailed information on growth prospects, along with riveting insights into the forecast assessment of the market.
Extensive primary and secondary researches have been employed to garner keen insights into the forecast study of the clinical trial packaging market. The report has further undergone a cross-validation by in-house professionals to make the clinical trial packaging market report one-of-its-kind, with the highest credibility.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
2. Market Viewpoint
2.1. Market Definition
2.2. Market Taxonomy
3. Clinical Trial Packaging Market Overview
3.1. Introduction
3.2. Macro-economic Factors – Correlation Analysis
3.3. Forecast Factors – Relevance & Impact
3.4. Clinical Trial Packaging Market Value Chain Analysis
3.4.1. Exhaustive List of Active Participants
3.4.1.1. Manufacturers
3.4.1.2. Distributors/Retailers
3.4.1.3. End Users
3.4.2. Profitability Margins
4. Impact of COVID-19
4.1. Current Statistics and Probable Future Impact
4.2. Current Economic Projection – GDP/GVA and Probable Impact
4.3. Comparison of SAARs and Market Recovery, for Key Countries
4.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries
4.5. Impact of COVID-19 on Target Market
5. Clinical Trial Packaging Market Analysis
5.1. Pricing Analysis
5.1.1. Pricing Assumption
5.1.2. Price Projections By Region
5.2. Market Size (US$ Mn) and Forecast
5.2.1. Market Size and Y-o-Y Growth
5.2.2. Absolute $ Opportunity
6. Clinical Trial Packaging Market Dynamics
6.1. Drivers
6.2. Restraints
6.3. Opportunity Analysis
6.4. Trends
7. Global Clinical Trial Packaging Market Analysis and Forecast, By Packaging Type
7.1. Introduction
7.1.1. Market share and Basis Points (BPS) Analysis, By Packaging Type
7.1.2. Y-o-Y Growth Projections, By Packaging Type
7.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type
7.2.1. Syringes
7.2.2. Vials & Ampoules
7.2.3. Blisters
7.2.3.1. Cold Forming
7.2.3.2. Thermoforming
7.2.4. Tubes
7.2.5. Bottles
7.2.6. Bags & Pouches
7.2.7. Sachets
7.2.8. Kits or Packs
7.2.9. Others
7.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type
7.3.1. Syringes
7.3.2. Vials & Ampoules
7.3.3. Blisters
7.3.3.1. Cold Forming
7.3.3.2. Thermoforming
7.3.4. Tubes
7.3.5. Bottles
7.3.6. Bags & Pouches
7.3.7. Sachets
7.3.8. Kits or Packs
7.3.9. Others
7.4. Market Attractiveness Analysis, By Packaging Type
8. Global Clinical Trial Packaging Market Analysis and Forecast, By Material
8.1. Introduction
8.1.1. Market share and Basis Points (BPS) Analysis, By Material
8.1.2. Y-o-Y Growth Projections, By Material
8.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material
8.2.1. Plastic
8.2.1.1. PVC
8.2.1.2. PE
8.2.1.2.1. HDPE
8.2.1.2.2. LDPE
8.2.1.3. PP
8.2.1.4. Others
8.2.2. Glass
8.2.3. Metal
8.2.4. Paper
8.2.5. Corrugated Fiber
8.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material
8.3.1. Plastic
8.3.1.1. PVC
8.3.1.2. PE
8.3.1.2.1. HDPE
8.3.1.2.2. LDPE
8.3.1.3. PP
8.3.1.4. Others
8.3.2. Glass
8.3.3. Metal
8.3.4. Paper
8.3.5. Corrugated Fiber
8.4. Market Attractiveness Analysis, By Material
9. Global Clinical Trial Packaging Market Analysis and Forecast, By End Use
9.1. Introduction
9.1.1. Market share and Basis Points (BPS) Analysis, By End Use
9.1.2. Y-o-Y Growth Projections, By End Use
9.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use
9.2.1. Research Laboratories
9.2.2. Clinical Research Organization
9.2.3. Drug Manufacturing Facilities
9.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use
9.3.1. Research Laboratories
9.3.2. Clinical Research Organization
9.3.3. Drug Manufacturing Facilities
9.4. Market Attractiveness Analysis, By End Use
9.5. Prominent Trends
10. Global Clinical Trial Packaging Market Analysis and Forecast, By Region
10.1. Introduction
10.1.1. Market share and Basis Points (BPS) Analysis By Region
10.1.2. Y-o-Y Growth Projections By Region
10.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Region
10.2.1. North America
10.2.2. Latin America
10.2.3. Europe
10.2.4. Asia Pacific
10.2.5. Middle East & Africa (MEA)
10.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Region
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East & Africa (MEA)
10.4. Market Attractiveness Analysis By Region
10.5. Prominent Trends
11. North America Clinical Trial Packaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Market share and Basis Points (BPS) Analysis, By Country
11.1.2. Y-o-Y Growth Projections, By Country
11.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country
11.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Country
11.3.1. U.S.
11.3.2. Canada
11.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type
11.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type
11.5.1. Syringes
11.5.2. Vials & Ampoules
11.5.3. Blisters
11.5.3.1. Cold Forming
11.5.3.2. Thermoforming
11.5.4. Tubes
11.5.5. Bottles
11.5.6. Bags & Pouches
11.5.7. Sachets
11.5.8. Kits or Packs
11.5.9. Others
11.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material
11.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material
11.7.1. Plastic
11.7.1.1. PVC
11.7.1.2. PE
11.7.1.2.1. HDPE
11.7.1.2.2. LDPE
11.7.1.3. PP
11.7.1.4. Others
11.7.2. Glass
11.7.3. Metal
11.7.4. Paper
11.7.5. Corrugated Fiber
11.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use
11.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use
11.9.1. Research Laboratories
11.9.2. Clinical Research Organization
11.9.3. Drug Manufacturing Facilities
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Packaging Type
11.10.3. By Material
11.10.4. By End Use
11.11. Prominent Trends
11.12. Drivers and Restraints: Impact Analysis
12. Latin America Clinical Trial Packaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Market share and Basis Points (BPS) Analysis, By Country
12.1.2. Y-o-Y Growth Projections, By Country
12.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country
12.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Country
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Argentina
12.3.4. Rest of Latin America
12.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type
12.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type
12.5.1. Syringes
12.5.2. Vials & Ampoules
12.5.3. Blisters
12.5.3.1. Cold Forming
12.5.3.2. Thermoforming
12.5.4. Tubes
12.5.5. Bottles
12.5.6. Bags & Pouches
12.5.7. Sachets
12.5.8. Kits or Packs
12.5.9. Others
12.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material
12.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material
12.7.1. Plastic
12.7.1.1. PVC
12.7.1.2. PE
12.7.1.2.1. HDPE
12.7.1.2.2. LDPE
12.7.1.3. PP
12.7.1.4. Others
12.7.2. Glass
12.7.3. Metal
12.7.4. Paper
12.7.5. Corrugated Fiber
12.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use
12.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use
12.9.1. Research Laboratories
12.9.2. Clinical Research Organization
12.9.3. Drug Manufacturing Facilities
12.10. Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Packaging Type
12.10.3. By Material
12.10.4. By End Use
12.11. Prominent Trends
12.12. Drivers and Restraints: Impact Analysis
13. Europe Clinical Trial Packaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Market share and Basis Points (BPS) Analysis, By Country
13.1.2. Y-o-Y Growth Projections, By Country
13.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country
13.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Country
13.3.1. Germany
13.3.2. Spain
13.3.3. Italy
13.3.4. France
13.3.5. U.K.
13.3.6. BENELUX
13.3.7. Nordic
13.3.8. Russia
13.3.9. Poland
13.3.10. Rest of Europe
13.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type
13.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type
13.5.1. Syringes
13.5.2. Vials & Ampoules
13.5.3. Blisters
13.5.3.1. Cold Forming
13.5.3.2. Thermoforming
13.5.4. Tubes
13.5.5. Bottles
13.5.6. Bags & Pouches
13.5.7. Sachets
13.5.8. Kits or Packs
13.5.9. Others
13.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material
13.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material
13.7.1. Plastic
13.7.1.1. PVC
13.7.1.2. PE
13.7.1.2.1. HDPE
13.7.1.2.2. LDPE
13.7.1.3. PP
13.7.1.4. Others
13.7.2. Glass
13.7.3. Metal
13.7.4. Paper
13.7.5. Corrugated Fiber
13.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use
13.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use
13.9.1. Research Laboratories
13.9.2. Clinical Research Organization
13.9.3. Drug Manufacturing Facilities
13.10. Market Attractiveness Analysis
13.10.1. By Country
13.10.2. By Packaging Type
13.10.3. By Material
13.10.4. By End Use
13.11. Prominent Trends
13.12. Drivers and Restraints: Impact Analysis
14. Asia Pacific Clinical Trial Packaging Market Analysis and Forecast
14.1. Introduction
14.1.1. Market share and Basis Points (BPS) Analysis, By Country
14.1.2. Y-o-Y Growth Projections, By Country
14.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country
14.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Country
14.3.1. China
14.3.2. India
14.3.3. Japan
14.3.4. ASEAN
14.3.5. Australia and New Zealand
14.3.6. Rest of APAC
14.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type
14.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type
14.5.1. Syringes
14.5.2. Vials & Ampoules
14.5.3. Blisters
14.5.3.1. Cold Forming
14.5.3.2. Thermoforming
14.5.4. Tubes
14.5.5. Bottles
14.5.6. Bags & Pouches
14.5.7. Sachets
14.5.8. Kits or Packs
14.5.9. Others
14.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material
14.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material
14.7.1. Plastic
14.7.1.1. PVC
14.7.1.2. PE
14.7.1.2.1. HDPE
14.7.1.2.2. LDPE
14.7.1.3. PP
14.7.1.4. Others
14.7.2. Glass
14.7.3. Metal
14.7.4. Paper
14.7.5. Corrugated Fiber
14.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use
14.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use
14.9.1. Research Laboratories
14.9.2. Clinical Research Organization
14.9.3. Drug Manufacturing Facilities
14.10. Market Attractiveness Analysis
14.10.1. By Country
14.10.2. By Packaging Type
14.10.3. By Material
14.10.4. By End Use
14.11. Prominent Trends
14.12. Drivers and Restraints: Impact Analysis
15. Middle East and Africa Clinical Trial Packaging Market Analysis and Forecast
15.1. Introduction
15.1.1. Market share and Basis Points (BPS) Analysis, By Country
15.1.2. Y-o-Y Growth Projections, By Country
15.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country
15.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Country
15.3.1. North Africa
15.3.2. GCC countries
15.3.3. South Africa
15.3.4. Turkey
15.3.5. Rest of MEA
15.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type
15.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type
15.5.1. Syringes
15.5.2. Vials & Ampoules
15.5.3. Blisters
15.5.3.1. Cold Forming
15.5.3.2. Thermoforming
15.5.4. Tubes
15.5.5. Bottles
15.5.6. Bags & Pouches
15.5.7. Sachets
15.5.8. Kits or Packs
15.5.9. Others
15.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material
15.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material
15.7.1. Plastic
15.7.1.1. PVC
15.7.1.2. PE
15.7.1.2.1. HDPE
15.7.1.2.2. LDPE
15.7.1.3. PP
15.7.1.4. Others
15.7.2. Glass
15.7.3. Metal
15.7.4. Paper
15.7.5. Corrugated Fiber
15.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use
15.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use
15.9.1. Research Laboratories
15.9.2. Clinical Research Organization
15.9.3. Drug Manufacturing Facilities
15.10. Market Attractiveness Analysis
15.10.1. By Country
15.10.2. By Packaging Type
15.10.3. By Material
15.10.4. By End Use
15.11. Prominent Trends
15.12. Drivers and Restraints: Impact Analysis
16. Competitive Landscape
16.1. Market Structure
16.2. Competition Dashboard
16.3. Company Market Share Analysis
16.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)
16.5. Competition Deep Dive
(Global Players)
16.5.1. lcare Ltd.
16.5.1.1. Overview
16.5.1.2. Financials
16.5.1.3. Strategy
16.5.1.4. Recent Developments
16.5.1.5. SWOT Analysis
16.5.2. Fisher Clinical Services, Inc
16.5.2.1. Overview
16.5.2.2. Financials
16.5.2.3. Strategy
16.5.2.4. Recent Developments
16.5.2.5. SWOT Analysis
16.5.3. WuXi AppTec, Inc
16.5.3.1. Overview
16.5.3.2. Financials
16.5.3.3. Strategy
16.5.3.4. Recent Developments
16.5.3.5. SWOT Analysis
16.5.4. PCI Pharma Services
16.5.4.1. Overview
16.5.4.2. Financials
16.5.4.3. Strategy
16.5.4.4. Recent Developments
16.5.4.5. SWOT Analysis
16.5.5. Almac Group Limited
16.5.5.1. Overview
16.5.5.2. Financials
16.5.5.3. Strategy
16.5.5.4. Recent Developments
16.5.5.5. SWOT Analysis
16.5.6. PharMaterials Ltd
16.5.6.1. Overview
16.5.6.2. Financials
16.5.6.3. Strategy
16.5.6.4. Recent Developments
16.5.6.5. SWOT Analysis
16.5.7. PAREXEL International Corp
16.5.7.1. Overview
16.5.7.2. Financials
16.5.7.3. Strategy
16.5.7.4. Recent Developments
16.5.7.5. SWOT Analysis
16.5.8. Schreiner MediPharm
16.5.8.1. Overview
16.5.8.2. Financials
16.5.8.3. Strategy
16.5.8.4. Recent Developments
16.5.8.5. SWOT Analysis
16.5.9. Sharp Packaging Systems, LLC
16.5.9.1. Overview
16.5.9.2. Financials
16.5.9.3. Strategy
16.5.9.4. Recent Developments
16.5.9.5. SWOT Analysis
16.5.10. The Coghlan Group Inc
16.5.10.1. Overview
16.5.10.2. Financials
16.5.10.3. Strategy
16.5.10.4. Recent Developments
16.5.10.5. SWOT Analysis
16.5.11. Rubicon Research Private Limited
16.5.11.1. Overview
16.5.11.2. Financials
16.5.11.3. Strategy
16.5.11.4. Recent Developments
16.5.11.5. SWOT Analysis
16.5.12. Westrock Company
16.5.12.1. Overview
16.5.12.2. Financials
16.5.12.3. Strategy
16.5.12.4. Recent Developments
16.5.12.5. SWOT Analysis
16.5.13. Xerimis Inc
16.5.13.1. Overview
16.5.13.2. Financials
16.5.13.3. Strategy
16.5.13.4. Recent Developments
16.5.13.5. SWOT Analysis
16.5.14. Catalent, Inc
16.5.14.1. Overview
16.5.14.2. Financials
16.5.14.3. Strategy
16.5.14.4. Recent Developments
16.5.14.5. SWOT Analysis
16.5.15. Piramal Enterprises Ltd
16.5.15.1. Overview
16.5.15.2. Financials
16.5.15.3. Strategy
16.5.15.4. Recent Developments
16.5.15.5. SWOT Analysis
16.5.16. Corden Pharma GmbH
16.5.16.1. Overview
16.5.16.2. Financials
16.5.16.3. Strategy
16.5.16.4. Recent Developments
16.5.16.5. SWOT Analysis
16.5.17. NextPharma Technologies
16.5.17.1. Overview
16.5.17.2. Financials
16.5.17.3. Strategy
16.5.17.4. Recent Developments
16.5.17.5. SWOT Analysis
16.5.18. Sentry BioPharma Services
16.5.18.1. Overview
16.5.18.2. Financials
16.5.18.3. Strategy
16.5.18.4. Recent Developments
16.5.18.5. SWOT Analysis
16.5.19. Körber Medipak Systems AG
16.5.19.1. Overview
16.5.19.2. Financials
16.5.19.3. Strategy
16.5.19.4. Recent Developments
16.5.19.5. SWOT Analysis
16.5.20. DMB Consultancy
16.5.20.1. Overview
16.5.20.2. Financials
16.5.20.3. Strategy
16.5.20.4. Recent Developments
16.5.20.5. SWOT Analysis
*The list of companies is indicative in nature and is subject to change during the course of research
17. Assumptions and Acronyms Used
18. Research Methodology